Dec 13, 2013 by Dan CarrollMerck and GE Cling to Gains Despite Dow's StrugglesMerck wins a thumbs-up from an FDA committee on its latest drug, pushing shares into the green.
Dec 12, 2013 by Dan CarrollMerck's 2013 Leaves Questions Lingering for InvestorsThis top Dow health care stock has struggled through the patent cliff this year, but is Merck looking good heading into the final days of 2013?
Dec 12, 2013 by Dan CarrollCisco, UnitedHealth Lead the Dow's Struggling Stocks DownA tough day for stocks has left investors sitting in the red into the afternoon trading session.
Dec 10, 2013 by Dan CarrollMerck, Johnson & Johnson Slide on the Dow's DipMerck falls among a slow day for both Big Pharma and blue-chip stocks.
Dec 9, 2013 by Dan CarrollMcDonald's Sales Troubles Weighs Down the Dow's GainsGE rises to continue a successful year-to-date surge despite the Dow's wobbly day.
Dec 7, 2013 by Dan Carroll3 Big Impacts From Obamacare on America's Largest Health InsurersIn the wake of UnitedHealth's announcement that Obamacare could take a bite out of its earnings next year, here are three big ways that Obamacare could make waves -- for better and for worse -- in the insurance industry in 2014
Dec 7, 2013 by Dan CarrollThe 5 Fastest-Growing Countries in the WorldFrom Peru to China, meet the surging economies that make up the five fastest-growing countries in the world.
Dec 7, 2013 by Dan Carroll3 Budding Drug Superstars in This Big Pharma's FutureCan Bristol-Myers Squibb keep its amazing growth in 2013 going strong in the future? It'll rely on ballyhooed drugs like these to discover its future growth.
Dec 6, 2013 by Dan CarrollUnemployment's Fall to 7% Fuels a Huge Day for the DowIntel jumps after an upgrade today, while Disney keeps up its unrivaled run.
Dec 6, 2013 by Dan CarrollCan This Cardiac King Find Its Nerve?St. Jude Medical's a leader in neuromodulation, but with rivals crowding out the space, it's looking to move into the next generation of devices.
Dec 6, 2013 by Dan CarrollCan These 3 Diving Device Stocks Deliver in 2014?Volcano, Intuitive Surgical, and Edwards Lifesciences have taken a hit this year. Should you trust that a turnaround is on the way?
Dec 5, 2013 by Dan CarrollMicrosoft's Plunge Leads the Dow's Wobbly DipPfizer, JPMorgan both decline on a day of falling stocks across the market.
Dec 4, 2013 by Dan CarrollUnitedHealth Falls Victim to the Dow's Drop and ObamacareAmerica's largest insurer falls 0.5% after detailing the costs of Obamacare, while Microsoft beats the Dow's plunge.
Dec 3, 2013 by Dan CarrollMerck's Slide Helps Drag Down the Dow's Triple-Digit DropMerck and Pfizer both plunge into the red on a day of huge losses on the Dow Jones.
Dec 3, 2013 by Dan CarrollCan Merck Sustain 2013's Healthy Climb in the New Year?This Dow Jones health-care standout has surged this year, but is the worst of the patent cliff over for Merck?
Dec 2, 2013 by Dan CarrollWall Street Turns Negative on 3M as the Dow Bucks Good News AgainThe ISM's PMI shows an uptick in manufacturing, but that's not enough for the Dow Jones to hit the red. Meanwhile, UnitedHealth misses analyst estimates on next year's earnings while 3M plunges.
Nov 30, 2013 by Dan CarrollNovember's 3 Biggest Biotech BustsSarepta's huge drop leads a field of monthly losers that includes Aegerion's drop and Immunogen's plunge.
Nov 29, 2013 by Dan CarrollBrazil's Big Opportunity Can't Wait for This Health Care LeaderSmith & Nephew follows in the footsteps of Medtronic and Stryker in pushing overseas for its newest growth opportunities.
Nov 29, 2013 by Dan Carroll3 Surging Biotechs That Made Investors Rich in NovemberViroPharma, Idenix, and Geron all boomed in a big way for shareholders over the past month.
Nov 28, 2013 by Dan CarrollWill This Top Dow Health-Care Stock Stay Healthy in 2014?Pfizer's boomed in 2013, and with the patent cliff's worries beginning to subside, the stock could be ready to keep rolling in the new year.
